ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Analysts think GLP-1 drugs will have minor impact on insulin pump market and boost CGMs"
Episode Synopsis
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 12, 2023.
[Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.]
Zeta Surgical recently announced it won FDA clearance for its mixed reality cranial surgical navigation system. Fast Five hosts Sean Whooley and Danielle Kirsh explain what the navigation system is and how it assists surgeons.
Centinel Spine announced last week that it is divesting its spine fusion business. Find out what the sale means for the company, when the deal will close and what executives think about this strategic move.
Surgical robotics are in the news again. Quantum Surgical won CE mark approval for its surgical robot that treats lung tumors. Whooley explains the purpose of the robot and what the expanded approval follows.
Philips has launched a new ultrasound technology to assist with cancer diagnostics. Learn what the technology does and why it is important for clinicians and patients.
Analysts think that GLP-1 drugs may have a minor impact on the insulin pump market but could boost the use of continuous glucose monitors. Whooley details what the impact could be and what analysts think about the impact of this class of pharmaceuticals on the insulin delivery market.
[Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.]
Zeta Surgical recently announced it won FDA clearance for its mixed reality cranial surgical navigation system. Fast Five hosts Sean Whooley and Danielle Kirsh explain what the navigation system is and how it assists surgeons.
Centinel Spine announced last week that it is divesting its spine fusion business. Find out what the sale means for the company, when the deal will close and what executives think about this strategic move.
Surgical robotics are in the news again. Quantum Surgical won CE mark approval for its surgical robot that treats lung tumors. Whooley explains the purpose of the robot and what the expanded approval follows.
Philips has launched a new ultrasound technology to assist with cancer diagnostics. Learn what the technology does and why it is important for clinicians and patients.
Analysts think that GLP-1 drugs may have a minor impact on the insulin pump market but could boost the use of continuous glucose monitors. Whooley details what the impact could be and what analysts think about the impact of this class of pharmaceuticals on the insulin delivery market.
More episodes of the podcast Fast Five Medtech News Podcast
Edwards reports new outcomes with TAVR; SafeGuard wins breakthrough nod for biodegradable stent
15/03/2024
Former Stimwave CEO convicted of healthcare fraud; GE HealthCare establishes charitable foundation
14/03/2024
iRhythm closes offering worth more than $660M; FDA accepts Onward BCI into advisory program
12/03/2024
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
08/03/2024
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
06/03/2024
In God we trust